跳至主要内容
临床试验/NCT00498004
NCT00498004终止4 期

Randomized, Open Label, 8-Week Study of Quetiapine and Risperidone on Quality of Life in Female With Schizophrenia

Inje University1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2007年8月1日最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
终止
入组人数
100
试验地点
1
主要终点
QOL measured by Korean version of Heinrich's Quality of Life Scale

研究概览

简要总结

The primary objective of this study is to demonstrate clinical and statistical superiority of quetiapine compared to risperidone in Korean version of Heinrich's Quality of Life Scale after 8 weeks trial of drugs.

详细描述

Prolactin related adverse events are closely related to patient's perception on their illness and quality of life . Poor subjective wellbeing induced by prolactin elevation after antipsychotic drug treatment can complicate the clinical outcomes of treatment.Quetiapine has negligible effects on the elevation of prolactin and does not produce hyperprolactinemia related adverse events such as amenorrhea, galactorrhea that may disturb quality of life in famel patient. In this Randomized, Open Label, 8-week Study, the impact of quetiapine and risperidone on quality of life in female patients with schizophrenia will be compared.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
Female
接受健康志愿者
否

入选标准

  • •Diagnosis: Schizophrenia (DSM-IV)
  • •Female, Age: between 18-60 years
  • •Who either need first time treatment with antipsychotic drug or recently
  • •Sign written informed consent

排除标准

  • •Taking other psychiatric medications during last 30 days
  • •Refractory schizophrenia
  • •A current medical illness associated with sexual dysfunction
  • •Previous history of no response to quetiapine or risperidone treatment
  • •Previous enrolment or randomisation of treatment in the present study.
  • •Participation in a clinical study during the last 90 days.
  • •Alcohol or substance abuser

结局指标

主要结局

QOL measured by Korean version of Heinrich's Quality of Life Scale

时间窗: 8weeks

次要结局

  • Korean version of Female Sexual Function Index(8 weeks)
  • Korean version of Female Sexual Distress Scale(8 weeks)
  • Hormonal levels (Prolactin, Estradiol, Free Testosterone, FSH, LH(8 weeks)
  • Psychopathology (Brief Psychiatric Rating Scale)(8 weeks)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验